Skip to main content
Premium Trial:

Request an Annual Quote

Medicare to Cover Genomic Health's Oncotype DX Breast Cancer Test for DCIS

NEW YORK (GenomeWeb News) – Genomic Health said after the close of the market on Friday that the national Medicare contractor for the firm's Oncotype DX breast cancer test has expanded Medicare coverage for the test.

The contractor, Palmetto GBA, has expanded its coverage policy for all qualified Medicare patients to include those with ductal carcinoma in situ, or DCIS, Genomic Health said. The coverage policy took effect May 8.

The Redwood City, Calif.-based company said that detection of DCIS is increasing in the US with more than 50,000 patients diagnosed each year. The Oncotype DX DCIS Score predicts 10-year local recurrence, DCIS or invasive carcinoma, based on the patient's underlying tumor biology, Genomic Health said.

The company last week reported that revenues in the first quarter increased 8 percent year over year driven by adoption of its Onctotype DX products.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.